CLINICAL STUDIES

NAVIGATOR

A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma

Study Phase:

Phase 3

Criteria:

  • Male or Female 12 to 80 years of age
  • History of Asthma
  • Taking medication for Asthma
Register